CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for CreoSG Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

CreoSG Co Ltd
4F, Dongwon Bldg.,, 143-28,
Samseong-Dong, Gangnam-Gu
Phone: +82 221413000p:+82 221413000 SEOUL, 06130  South Korea Ticker: 040350040350
Business Summary
CreoSG Co Ltd, formerly Curocom Co Ltd, is a Korea-based company mainly engaged in solution business and distribution business. The Company operates through three segments. The Solutions Business segment is engaged in the development and provision of financial consulting and software for financial institutions. Additionally, the segment is engaged in the supply of core banking solutions BANCS-K framework and BANCS-K Package to banks and other financial institutions. The Distribution Business segment is engaged in the distribution business of computers, laptops, printers, and multi-function printers. The New Drug and Vaccine Development Business segment is engaged in the development of vaccines for acquired immunodeficiency syndrome(AIDS), corona virus disease 19 (COVID-19) vaccine and other infectious diseases, and research and development of super antibiotics for Staphylococcus aureus.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
7373 Computer integrated systems design
7371 Computer programming services
7372 Prepackaged software
5045 Computers and computer peripheral equipment and software
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jung GiCho 52 3/25/2010 12/31/2005
Internal Auditor Seong SuLee 39 3/25/2010 3/25/2010
Director HoGwon 49 3/30/2009 3/30/2009
4 additional Officers and Directors records available in full report.

Business Names
Business Name
040350
Curocom Co., Ltd.
GNT Works Co., Ltd.
SUMAGEN

General Information
Number of Employees: 36 (As of 12/31/2015)
Outstanding Shares: 151,655,728 (As of 10/11/2024)
Shareholders: 15,724
Stock Exchange: KDQ
Fax Number: +82 221413097


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024